Rivernorth Capital Management’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,000	Closed	-$1.01M	–	733
2021 Q3	$1.01M	Hold	10,000	–	–	0.05%	246
2021 Q2	$996K	Hold	10,000	–	–	0.06%	227
2021 Q1	$982K	Buy	+10,000	New	+$982K	0.06%	217